Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support

Prashant Nanasaheb Mohite; Aron Frederik Popov; Armin Bartsch; Bartlomiej Zych; Dhruva Dhar; Ajay Moza; Heike Krueger; André Ruediger Simon

doi:10.1186/1749-8090-6-164

Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support

J Cardiothorac Surg. 2011 Dec 20:6:164. doi: 10.1186/1749-8090-6-164.

Authors

Prashant Nanasaheb Mohite¹, Aron Frederik Popov, Armin Bartsch, Bartlomiej Zych, Dhruva Dhar, Ajay Moza, Heike Krueger, André Ruediger Simon

Affiliation

¹ Department of Cardiothoracic Transplantation & Mechanical support, Royal Brompton & Harefield NHS Trust, London, United Kingdom.

Abstract

The prevalence of myocardial involvement in influenza infection ranges from 0% to 12%. The 2009 pH1N1 influenza virus, formerly known as swine flu, first appeared in Mexico and the United States of America in March and April 2009 and has swept the globe with unprecedented speed. We report a case of fulminant myocarditis associated with this virus treated successfully using extra-corporal membrane oxygenator.

Publication types

Case Reports

MeSH terms

Adolescent
Antiviral Agents / therapeutic use*
Extracorporeal Circulation / methods*
Female
Follow-Up Studies
Humans
Influenza A Virus, H1N1 Subtype / genetics
Influenza A Virus, H1N1 Subtype / immunology*
Influenza A Virus, H1N1 Subtype / isolation & purification
Influenza Vaccines / therapeutic use*
Influenza, Human / complications*
Influenza, Human / drug therapy
Influenza, Human / virology
Myocarditis / etiology
Myocarditis / therapy*
Myocarditis / virology
Oseltamivir / therapeutic use*
Polymerase Chain Reaction
RNA, Viral / analysis

Substances

Antiviral Agents
Influenza Vaccines
RNA, Viral
Oseltamivir